C-Terminal Fragment, Aβ(39–42)-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity

[Image: see text] Since the introduction of acetyl cholinesterase inhibitors as the first approved drugs by the US Food and Drug Administration for Alzheimer’s disease (AD) in clinics, less than satisfactory success in the design of anti-AD agents has impelled the scientists to also focus toward inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Sunil, Maurya, Indresh Kumar, Yadav, Nitin, Thota, Chaitanya Kumar, Kumar, Vinod, Tikoo, Kulbhushan, Chauhan, Virander Singh, Jain, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645473/
https://www.ncbi.nlm.nih.gov/pubmed/31459130
http://dx.doi.org/10.1021/acsomega.8b01522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645473/
https://www.ncbi.nlm.nih.gov/pubmed/31459130
http://dx.doi.org/10.1021/acsomega.8b01522

Ejemplares similares